IVUS-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation (IVUS-XPL)

Unlike earlier, smaller imaging-guidance trials that showed better-looking stents without better outcomes, IVUS-XPL demonstrated an actual clinical benefit — in the right setting.

In 1,400 patients with long coronary lesions (the kind most prone to complications), intravascular-ultrasound-guided stent placement produced a significantly lower rate of major adverse cardiac events at one year than angiography guidance, driven mainly by fewer repeat procedures for the treated lesion. Seeing the vessel from the inside helped operators place and expand stents better, and that translated into fewer failures.

The result is more persuasive than the procedural-surrogate trials because its endpoint was clinical events. It established a genuine role for IVUS guidance in complex, long-lesion stenting — a population where the extra information earns its keep.

We rate the evidence strong. A well-conducted randomized trial with a clinical endpoint, IVUS-XPL is among the stronger pieces of evidence supporting intravascular imaging guidance for higher-risk lesions.